LRG GIST Patient Registry
2026年7月8日 更新者：The Life Raft Group
Life Raft Group GIST Registry Protocol
The Life Raft Group (LRG) Patient Registry is a structured database that collects comprehensive information about individuals diagnosed with GIST.
The purpose of this registry is to facilitate research, improve understanding of the disease, track patient outcomes, and ultimately enhance patient care.
調査の概要
状態
募集
詳細な説明
An organization called the Life Raft Group (LRG) wants to find out more about a cancer called Gastrointestinal Stromal Tumors (GIST) as well as other cancers that may or may not be related to GIST.
To collect this information, LRG has created a research registry.
A registry is a place where medical information, family history and other related information from patients is collected and stored for medical research.
The purpose of the Life Raft Group GIST registry is to collect and store medical information and other information from individuals with the same disease or other cancers that share commonalities such as molecular targets, treatments, or other factors.
Information from patients in this registry will be used for medical research to better understand GIST and these other diseases.
Scientists studying GIST and these other diseases need more accurate, real-world information to understand how these diseases affect people.
People with GIST and other related or unrelated diseases are being asked if they would like to participate in the Life Raft Group registry.
The Life Raft Group GIST registry is also linked to a tissue bank, which is a place that stores tumor tissue, blood or other samples from patients.
Participants may also be asked to provide samples to the tissue bank.
Participants would need to read and sign a separate consent form about the tissue bank.
Participants do not have to take part in any other Life Raft Group activities, including the tissue bank and online forums, to take part in this registry.
研究の種類
観察的
入学 (推定)
5000
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Patient Registry Department
- 電話番号：973-837-9092
- メール：patientregistrydepartment@liferaftgroup.org
研究場所
-
-
New Jersey
-
Wayne、New Jersey、アメリカ、07470
- 募集
- The Life Raft Group
-
コンタクト：
- 電話番号：973-837-9092
- メール：patientregistrydepartment@liferaftgroup.org
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
サンプリング方法
非確率サンプル
調査対象母集団
Gastrointestinal Stromal Tumor diagnosis
説明
Inclusion Criteria:
- Gastrointestinal Stromal Tumor diagnosis
- Provide written and informed consent
Exclusion Criteria:
-
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Overall survival
時間枠：From the date of registry enrollment until death from any cause, assessed through follow-up for up to 25 years.
|
Time from registry enrollment until death from any cause.
|
From the date of registry enrollment until death from any cause, assessed through follow-up for up to 25 years.
|
|
Progression Free Survival
時間枠：From the date of registry enrollment until the first documented disease progression or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
Time from registry enrollment until documented disease progression or death, whichever occurs first.
|
From the date of registry enrollment until the first documented disease progression or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
|
Recurrence Free Survival
時間枠：From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
Time from registry enrollment (or from complete surgical resection, if that is the clinically relevant starting point) until the first documented recurrence of GIST or death from any cause, whichever occurs first.
|
From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
|
Disease Free Survival
時間枠：From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
Disease-free survival is defined as the time from complete surgical resection of localized GIST until the first documented recurrence of GIST or death from any cause, whichever occurs first.
|
From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.
|
|
Time of Medication
時間枠：From the date of treatment initiation until permanent discontinuation of the medication for any reason, assessed through follow-up for up to 25 years.
|
Duration of treatment with a specific systemic therapy (e.g., imatinib, sunitinib, regorafenib, ripretinib), measured from treatment initiation until permanent discontinuation for any reason, including disease progression, toxicity, patient preference, or death.
|
From the date of treatment initiation until permanent discontinuation of the medication for any reason, assessed through follow-up for up to 25 years.
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2013年4月1日
一次修了 (推定)
2099年12月31日
研究の完了 (推定)
2099年12月31日
試験登録日
最初に提出
2026年7月1日
QC基準を満たした最初の提出物
2026年7月8日
最初の投稿 (実際)
2026年7月13日
学習記録の更新
投稿された最後の更新 (実際)
2026年7月13日
QC基準を満たした最後の更新が送信されました
2026年7月8日
最終確認日
2026年7月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
要旨の臨床試験
-
The First Affiliated Hospital with Nanjing Medical...募集
-
Universität Duisburg-Essenまだ募集していません
-
Arog Pharmaceuticals, Inc.Centre Leon Berard; Fox Chase Cancer Centerわからない
-
Kumquat Biosciences Inc.募集要旨 | 消化器腫瘍 | GIST - 消化管間質腫瘍 | 消化管間質腫瘍 | GIST 転移性がんアメリカ
-
Centre Leon Berard募集C-KIT 変異 | 転移性消化管間質腫瘍 (GIST) | 進行性消化管間質腫瘍 (GIST)フランス
-
Second Affiliated Hospital, School of Medicine,...まだ募集していません
-
Centre Leon Berard募集転移性消化管間質腫瘍 | 切除不能な消化管間質腫瘍 (GIST) | 局所進行消化管間質腫瘍 (GIST)フランス